AI software-based diabetes care reduces heart, kidney ailments by 32%: Study

NEW DELHI: Can Artificial Intelligence (AI)- enabled software improve clinical outcomes in patients with type II Diabetes and reduce the risk of heart and kidney diseases better than usual clinical care alone? A combined study conducted by AIIMs and other medical research centres suggests so!

In the study, a randomised control trial was conducted on diabetics with a Clinical Decision Support System (CDSS) software. The trial showed a 28 per cent reduction in macrovascular events like heart disease and neuropathy compared to routine medical care given to diabetic patients. It also presented a 32 per cent reduction in the occurrence of diabetic eye disease, decline in kidney function, and nerve pain.